Generic statin options can save the US $11.9B per year The study tracked five generic statins: atorvastatin, rosuvastatin, simvastatin, lovastatin and pravastatin.Read more about Generic statin options can save the US $11.9B per year
In-hospital mortality more common among COVID-19 patients with heart failure The authors also noted that cardiac complications such as myocarditis, MI and new-onset heart failure were rare during hospitalization for COVID-19.Read more about In-hospital mortality more common among COVID-19 patients with heart failure
DAPT after PCI can stop after 1 month, new research confirms The study, published in the Journal of the American College of Cardiology, examined outcomes from more than 3,000 patients. Read more about DAPT after PCI can stop after 1 month, new research confirms
Certain patients with chronic kidney disease face a higher risk of death after TAVR No such trend was reported among patients with end-stage kidney disease.Read more about Certain patients with chronic kidney disease face a higher risk of death after TAVR
Aspirin use may increase your risk of heart failure Doctors may not want to prescribe aspirin to patients presenting with obesity, high blood pressure, diabetes or a number of other risk factors.Read more about Aspirin use may increase your risk of heart failure
Some hospitalized COVID-19 patients may need anticoagulation therapy at discharge Researchers focused on rates of venous thromboembolism among COVID-19 patients at their own health system, sharing their work in JAMA Network Open.Read more about Some hospitalized COVID-19 patients may need anticoagulation therapy at discharge
What we know about COVID-19 and cardiogenic shock Photo by Sharon McCutcheon via Unsplash The full analysis was published in Circulation: Heart Failure. Read more about What we know about COVID-19 and cardiogenic shock
Multicenter trial to evaluate IVL treatment for peripheral lesions below the knee The Disrupt BTK II study will include 250 patients overall. Read more about Multicenter trial to evaluate IVL treatment for peripheral lesions below the knee
Data-driven ICM device management: EP’s ‘game-changer’ is building momentum The world of EP keeps getting busier and busier, and ICMs make it easier for clinicians to keep up. Read more about Data-driven ICM device management: EP’s ‘game-changer’ is building momentum
New study compares polymer and polymer-free drug-eluting stents after 3 years The analysis included outcomes data from nearly 1,500 PCI patients. Read more about New study compares polymer and polymer-free drug-eluting stents after 3 years